Breakthrough 3D Printing Ink! Bringing Artificial Active Skin Closer to Reality

Breakthrough 3D Printing Ink! Bringing Artificial Active Skin Closer to Reality

To address the critical challenge of “how to provide functional vascular networks for new tissues,” a joint research team from Linköping University and Sahlgrenska University Hospital in Sweden has developed a biphasic particle bioink based on gelatin and hyaluronic acid, named μInk. This material can construct dermal tissue substitutes with ultra-high cell density through 3D … Read more

DANAMI 3-PRIMULTI Substudy – Complete Revascularization Guided by FFR Improves Prognosis in STEMI Patients with Severe Nonculprit Lesions

DANAMI 3-PRIMULTI Substudy - Complete Revascularization Guided by FFR Improves Prognosis in STEMI Patients with Severe Nonculprit Lesions

Research Background In patients with ST-segment elevation myocardial infarction (STEMI), approximately 50% have multivessel disease (MVD), which is associated with a poor prognosis, especially when there are three-vessel lesions or chronic total occlusions. Although emergency PCI is the standard treatment for STEMI, there is still controversy regarding the management strategy for nonculprit lesions (complete revascularization … Read more

Subgroup Analysis of DANAMI-3-PRIMULTI: The Impact of Age on Prognosis After Complete Revascularization

Subgroup Analysis of DANAMI-3-PRIMULTI: The Impact of Age on Prognosis After Complete Revascularization

Research Background With the increasing number of elderly patients receiving primary percutaneous coronary intervention (PPCI), the management strategies for non-culprit lesions have become controversial. Although multiple studies support that complete revascularization (treating all significant stenosed vessels) can improve prognosis, the benefits for elderly patients (≥75 years) remain unclear due to their comorbidities and shorter life … Read more

DANAMI-3-PRIMULTI Substudy—Cardiac Magnetic Resonance Confirms the Impact on Cardiac Structure and Function

DANAMI-3-PRIMULTI Substudy—Cardiac Magnetic Resonance Confirms the Impact on Cardiac Structure and Function

Research Background Patients with ST-segment elevation myocardial infarction (STEMI) combined with multivessel disease (MVD) account for approximately 45% of all STEMI patients, and they have a poorer clinical prognosis. Previous studies (such as PRAMI, CvLPRIT) have shown that complete revascularization (treating all significantly narrowed vessels) can reduce major adverse cardiovascular events (MACE) compared to treating … Read more

Analysis of Bleeding Events in the DANAMI-3-PRIMULTI Substudy

Analysis of Bleeding Events in the DANAMI-3-PRIMULTI Substudy

Research Background and Objectives In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD), the strategy of complete revascularization (CRV) can reduce ischemic events, but its impact on bleeding risk remains unclear. Core Questions: – Does staged complete revascularization (FFR-guided) during hospitalization increase the risk of severe bleeding? – What is the impact … Read more